Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACON Laboratories has an extensive portfolio of FDA-cleared and CE-marked point-of-care diagnostic devices for diabetes care, infectious diseases including COVID‑19, pregnancy testing, urinalysis, allergy screening and more. Their products are widely used globally in both professional healthcare settings and at-home environments. The Flowflex SARS-CoV‑2 Rapid Antigen Test was among the first widely available COVID rapid tests in many markets.[1][2][6] No clinical trial results typical of therapeutics companies apply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACON Laboratories.